PGC-1α and exercise in the control of body weight

International Journal of Obesity

Volumn 36, Issue 11, 2012, Pages 1428-1435

  Summermatter, S ^a   Handschin, C ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

energy expenditure; exercise; PGC 1a; thermogenesis; weight control

Indexed keywords

GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ENERGY EXPENDITURE; EXERCISE; GENE SWITCHING; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; METABOLIC SYNDROME X; METABOLISM; MUSCLE CONTRACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; THERMOGENESIS; TRANSCRIPTION REGULATION; WEIGHT CONTROL;

ANIMALS; BODY WEIGHT; CEREBROVASCULAR DISORDERS; EXERCISE; HEAT-SHOCK PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; METABOLIC SYNDROME X; MICE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OBESITY; PROTEIN KINASES; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; WEIGHT LOSS;

EID: 84869080596     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.12     Document Type: Review

References (99)

1. Bogers RP, Barte JC, Schipper CM, Vijgen SM, de Hollander EL, Tariq L et al. Relationship between costs of lifestyle interventions and weight loss in overweight adults. Obes Rev 2010; 11: 51-61.
2. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity 2008; 16: 2323-2330.
3. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643.
4. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. Cmaj 2007; 176: S1-S13.
5. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 847-853.
6. Muoio DM, Newgard CB. Obesity-related derangements in metabolic regulation. Ann Rev Biochem 2006; 75: 367-401.
7. Dyson PA. The therapeutics of lifestyle management on obesity. Diabetes Obes Metab 2010; 12: 941-946.
8. Horton ES. Effects of lifestyle changes to reduce risks of diabetes and associated cardiovascular risks: results from large scale efficacy trials. Obesity 2009; 17 Suppl 3: S43-S48.
9. Stunkard AJ. Current views on obesity. Am J Med 1996; 100: 230-236.
10. Bacon L, Aphramor L. Weight science: evaluating the evidence for a paradigm shift. Nutr J 2011; 10: 9.
11. Ayyad C, Andersen T. Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999. Obes Rev 2000; 1: 113-119.
12. Rosenbaum M, Leibel RL. Adaptive thermogenesis in humans. Int J Obes 2010; 34 Suppl 1: S47-S55.
13. Dulloo AG, Jacquet J, Seydoux J, Montani JP. The thrifty catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. Int J Obes 2006; 30 Suppl 4: S23-S35.
14. Weyer C, Walford RL, Harper IT, Milner M, MacCallum T, Tataranni PA et al. Energy metabolism after 2 y of energy restriction: the biosphere 2 experiment. Am J Clin Nutr 2000; 72: 946-953.
15. Cettour-Rose P, Samec S, Russell AP, Summermatter S, Mainieri D, Carrillo-Theander C et al. Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: a link between catch-up growth and later metabolic syndrome. Diabetes 2005; 54: 751-756.
16. Summermatter S, Marcelino H, Arsenijevic D, Buchala A, Aprikian O, Assimacopoulos-Jeannet F et al. Adipose tissue plasticity during catch-up fat driven by thrifty metabolism: relevance for muscle-adipose glucose redistribution during catch-up growth. Diabetes 2009; 58: 2228-2237.
17. Dulloo AG. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity. Horm Res 2006; 65 (Suppl 3): 90-97.
18. Chakravarthy MV, Booth FW. Eating, exercise, and thrifty'' genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol 2004; 96: 3-10.
19. Booth FW, Laye MJ, Lees SJ, Rector RS, Thyfault JP. Reduced physical activity and risk of chronic disease: the biology behind the consequences. Eur J Appl Physiol 2008; 102: 381-390.
20. Matsakas A, Narkar VA. Endurance exercise mimetics in skeletal muscle. Curr Sports Med Rep 2010; 9: 227-232.
21. Richter EA, Kiens B, Wojtaszewski JF. Can exercise mimetics substitute for exercise? Cell metabolism 2008; 8: 96-98.
22. Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 2006; 116: 615-622.
23. Jorgensen SB, Richter EA, Wojtaszewski JF. Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise. J Physiol 2006; 574 (Pt 1): 17-31.
24. Gibala MJ, McGee SL, Garnham AP, Howlett KF, Snow RJ, Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1alpha in human skeletal muscle. J Appl Physiol 2009; 106: 929-934.
25. Handschin C. Regulation of skeletal muscle cell plasticity by the peroxisome proliferator-activated receptor gamma coactivator 1alpha. J Recept Signal Transduct Res 2010; 30: 376-384.
26. Suwa M, Nakano H, Radak Z, Kumagai S. Endurance exercise increases the SIRT1 and peroxisome proliferator-activated receptor gamma coactivator-1alpha protein expressions in rat skeletal muscle. Metabolism 2008; 57: 986-998.
27. Gurd BJ. Deacetylation of PGC-1alpha by SIRT1: importance for skeletal muscle function and exercise-induced mitochondrial biogenesis. Appl Physiol Nutr Metab 2011; 36: 589-597.
28. Philp A, Chen A, Lan D, Meyer GA, Murphy AN, Knapp AE et al. Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial biogenesis or peroxisome proliferator-activated receptor-\{gamma\} coactivator-1\{alpha\} (pgc-1\{alpha\}) deacetylation following endurance exercise. J Biol Chem 2011; 286: 30561-30570.
29. Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A 2003; 100: 7111-7116.
30. Egan B, Carson BP, Garcia-Roves PM, Chibalin AV, Sarsfield FM, Barron N et al. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor coactivator-1 mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 2010; 588 (Pt 10): 1779-1790.
31. Miura S, Kawanaka K, Kai Y, Tamura M, Goto M, Shiuchi T et al. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation. Endocrinology 2007; 148: 3441-3448.
32. Tadaishi M, Miura S, Kai Y, Kawasaki E, Koshinaka K, Kawanaka K et al. Effect of exercise intensity and AICAR on isoform-specific expressions of murine skeletal muscle PGC-1alpha mRNA: a role of beta-adrenergic receptor activation. Am J Physiol Endocrinol Metab 2011; 300: E341-E349.
33. Norrbom JM, Sallstedt EK, Fischer H, Sundberg CJ, Rundqvist H, Gustafsson T. Alternative splice variant PGC-1\{alpha\}-b is strongly induced by exercise in human skeletal muscle. Am J Physiol Endocrinol Metab 2011; 301: E1092-E1098.
34. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002; 418: 797-801.
35. Summermatter S, Turnheer R, Santos G, Mosca B, Baum O, Treves S et al. Remodeling of calcium handling in skeletal muscle through PGC-1\{alpha\}: impact on force, fatigability and fiber type. Am J Physiol Cell Physiol 2012; 302: C88-C99.
36. Handschin C, Choi CS, Chin S, Kim S, Kawamori D, Kurpad AJ et al. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. J Clin Invest 2007; 117: 3463-3474.
37. Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, Lebrasseur NK et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J Biol Chem 2007; 282: 30014-30021.
38. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 2008; 451: 1008-1012.
39. Pedersen BK. Muscles and their myokines. J Exp Biol 2011; 214 (Pt 2): 337-346.
40. Summermatter S, Troxler H, Santos G, Handschin C. Coordinated balancing of muscle oxidative metabolism through PGC-1alpha increases metabolic flexibility and preserves insulin sensitivity. Biochem Biophys Res Commun 2011; 408: 180-185.
41. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008; 7: 45-56.
42. Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FG et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 2010; 18: 1695-1700.
43. An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, Shulman GI et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and wholeanimal insulin resistance. Nat Med 2004; 10: 268-274.
44. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-948.
45. Koves TR, Li P, An J, Akimoto T, Slentz D, Ilkayeva O et al. Peroxisome proliferatoractivated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem 2005; 280: 33588-33598.
46. Summermatter S, Baum O, Santos G, Hoppeler H, Handschin C. Peroxisome proliferator-activated receptor \{gamma\} coactivator 1\{alpha\} (PGC-1\{alpha\}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway. J Biol Chem 2010; 285: 32793-32800.
47. Wende AR, Schaeffer PJ, Parker GJ, Zechner C, Han DH, Chen MM et al. A role for the transcriptional coactivator PGC-1alpha in muscle refueling. J Biol Chem 2007; 282: 36642-36651.
48. Wende AR, Huss JM, Schaeffer PJ, Giguere V, Kelly DP. PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol 2005; 25: 10684-10694.
49. Choi CS, Befroy DE, Codella R, Kim S, Reznick RM, Hwang YJ et al. Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc Natl Acad Sci USA 2008; 105: 19926-19931.
50. Levine JA. Non-exercise activity thermogenesis (NEAT). Nutr Rev 2004; 62 (7 Pt 2): S82-S97.
51. Levine JA, Lanningham-Foster LM, McCrady SK, Krizan AC, Olson LR, Kane PH et al. Interindividual variation in posture allocation: possible role in human obesity. Science 2005; 307: 584-586.
52. Dulloo AG, Seydoux J, Jacquet J. Adaptive thermogenesis and uncoupling proteins: a reappraisal of their roles in fat metabolism and energy balance. Physiol Behav 2004; 83: 587-602.
53. Zurlo F, Larson K, Bogardus C, Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 1990; 86: 1423-1427.
54. St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB et al. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 2003; 278: 26597-26603.
55. O'Hagan KA, Cocchiglia S, Zhdanov AV, Tambuwala MM, Cummins EP, Monfared M et al. PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. Proc Natl Acad Sci U S A 2009; 106: 2188-2193.
56. Austin S, Klimcakova E, St-Pierre J. Impact of PGC-1alpha on the topology and rate of superoxide production by the mitochondrial electron transport chain. Free Radic Biol Med 2011; 51: 2243-2248.
57. Calvo JA, Daniels TG, Wang X, Paul A, Lin J, Spiegelman BM et al. Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake. J Appl Physiol 2008; 104: 1304-1312.
58. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A coldinducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998; 92: 829-839.
59. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004; 84: 277-359.
60. Nedergaard J, Cannon B. The novel' uncoupling' proteins UCP2 and UCP3: what do they really do? Pros and cons for suggested functions. Exp Physiol 2003; 88: 65-84.
61. MacLellan JD, Gerrits MF, Gowing A, Smith PJ, Wheeler MB, Harper ME. Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells. Diabetes 2005; 54: 2343-2350.
62. Cadenas S, Buckingham JA, Samec S, Seydoux J, Din N, Dulloo AG et al. UCP2 and UCP3 rise in starved rat skeletal muscle but mitochondrial proton conductance is unchanged. FEBS Lett 1999; 462: 257-260.
63. Nabben M, Shabalina IG, Moonen-Kornips E, van Beurden D, Cannon B, Schrauwen P et al. Uncoupled respiration, ROS production, acute lipotoxicity and oxidative damage in isolated skeletal muscle mitochondria from UCP3-ablated mice. Biochimica et biophysica acta 2011; 1807: 1095-1105.
64. Solinas G, Summermatter S, Mainieri D, Gubler M, Pirola L, Wymann MP et al. The direct effect of leptin on skeletal muscle thermogenesis is mediated by substrate cycling between de novo lipogenesis and lipid oxidation. FEBS Lett 2004; 577: 539-544.
65. Solinas G, Summermatter S, Mainieri D, Gubler M, Montani JP, Seydoux J et al. Corticotropin-releasing hormone directly stimulates thermogenesis in skeletal muscle possibly through substrate cycling between de novo lipogenesis and lipid oxidation. Endocrinology 2006; 147: 31-38.
66. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003; 100: 8466-8471.
67. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
68. Choi S, Liu X, Li P, Akimoto T, Lee SY, Zhang M et al. Transcriptional profiling in mouse skeletal muscle following a single bout of voluntary running: evidence of increased cell proliferation. J Appl Physiol 2005; 99: 2406-2415.
69. Handschin C, Kobayashi YM, Chin S, Seale P, Campbell KP, Spiegelman BM. PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Gene Dev 2007; 21: 770-783.
70. Geng T, Li P, Yin X, Yan Z. PGC-1alpha promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice. Am J Pathol 2011; 178: 1738-1748.
71. Liang H, Balas B, Tantiwong P, Dube J, Goodpaster BH, O'Doherty RM et al. Whole body overexpression of PGC-1alpha has opposite effects on hepatic and muscle insulin sensitivity. Am J Physiol Endocrinol Metab 2009; 296: E945-E954.
72. Steinberg GR, Watt MJ, McGee SL, Chan S, Hargreaves M, Febbraio MA et al. Reduced glycogen availability is associated with increased AMPKalpha2 activity, nuclear AMPKalpha2 protein abundance, and GLUT4 mRNA expression in contracting human skeletal muscle. Appl Physiol Nutr Metab 2006; 31: 302-312.
73. Wojtaszewski JF, Jorgensen SB, Hellsten Y, Hardie DG, Richter EA. Glycogendependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMPactivated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 2002; 51: 284-292.
74. Richter EA, Ruderman NB. AMPK and the biochemistry of exercise: implications for human health and disease. Biochem J 2009; 418: 261-275.
75. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006; 127: 397-408.
76. O'Neill HM, Maarbjerg SJ, Crane JD, Jeppesen J, Jorgensen SB, Schertzer JD et al. AMP-activated protein kinase (AMPK) \{beta\}1\{beta\}2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci USA 2011; 108: 16092-16097.
77. Chambers MA, Moylan JS, Smith JD, Goodyear LJ, Reid MB. Stretch-stimulated glucose uptake in skeletal muscle is mediated by reactive oxygen species and p38 MAP-kinase. J Physiol 2009; 587 (Pt 13): 3363-3373.
78. Lefort N, St-Amand E, Morasse S, Cote CH, Marette A. The alpha-subunit of AMPK is essential for submaximal contraction-mediated glucose transport in skeletal muscle in vitro. Am J Physiol Endocrinol Metab 2008; 295: E1447-E1454.
79. Merry TL, Lynch GS, McConell GK. Downstream mechanisms of nitric oxidemediated skeletal muscle glucose uptake during contraction. Am J Physiol Regul Integr Comp Physiol 2010; 299: R1656-R1665.
80. Zhang SJ, Sandstrom M, Ahlsen M, Ivarsson N, Zhu H, Ma J et al. 2-Methoxyoestradiol inhibits glucose transport in rodent skeletal muscle. Exp Physiol 2010; 95: 892-898.
81. Fernandez C, Hansson O, Nevsten P, Holm C, Klint C. Hormone-sensitive lipase is necessary for normal mobilization of lipids during submaximal exercise. Am J Physiol Endocrinol Metab 2008; 295: E179-E186.
82. Prats C, Donsmark M, Qvortrup K, Londos C, Sztalryd C, Holm C et al. Decrease in intramuscular lipid droplets and translocation of HSL in response to muscle contraction and epinephrine. J Lipid Res 2006; 47: 2392-2399.
83. Ivy JL. Muscle glycogen synthesis before and after exercise. Sports Med 1991; 11: 6-19.
84. Janiszewski PM, Ross R. Physical activity in the treatment of obesity: beyond body weight reduction. Appl Physiol Nutr Metab 2007; 32: 512-522.
85. Musi N, Hirshman MF, Arad M, Xing Y, Fujii N, Pomerleau J et al. Functional role of AMP-activated protein kinase in the heart during exercise. FEBS Lett 2005; 579: 2045-2050.
86. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 2000; 106: 847-856.
87. Qi Z, He J, Su Y, He Q, Liu J, Yu L et al. Physical exercise regulates p53 activity targeting SCO2 and increases mitochondrial COX biogenesis in cardiac muscle with age. PLoS One 2011; 6: e21140.
88. Boveris A, Navarro A. Systemic and mitochondrial adaptive responses to moderate exercise in rodents. Free Radic Biol Med 2008; 44: 224-229.
89. Little JP, Safdar A, Benton CR, Wright DC. Skeletal muscle and beyond: the role of exercise as a mediator of systemic mitochondrial biogenesis. Appl Physiol Nutr Metab 2011; 36: 598-607.
90. Lira VA, Benton CR, Yan Z, Bonen A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Physiol Endocrinol Metab 2010; 299: E145-E161.
91. Miura S, Kai Y, Ono M, Ezaki O. Overexpression of peroxisome proliferatoractivated receptor gamma coactivator-1alpha down-regulates GLUT4 mRNA in skeletal muscles. J Biol Chem 2003; 278: 31385-31390.
92. Miura S, Tomitsuka E, Kamei Y, Yamazaki T, Kai Y, Tamura M et al. Overexpression of peroxisome proliferator-activated receptor gamma co-activator-1alpha leads to muscle atrophy with depletion of ATP. Am J Pathol 2006; 169: 1129-1139.
93. Handschin C. The biology of PGC-1alpha and its therapeutic potential. Trends Pharmacol Sci 2009; 30: 322-329.
94. McCarty MF. Up-regulation of PPARgamma coactivator-1alpha as a strategy for preventing and reversing insulin resistance and obesity. Med Hypotheses 2005; 64: 399-407.
95. Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 2003; 24: 78-90.
96. Russell LK, Mansfield CM, Lehman JJ, Kovacs A, Courtois M, Saffitz JE et al. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stagedependent manner. Circ Res 2004; 94: 525-533.
97. Bergouignan A, Rudwill F, Simon C, Blanc S. Physical inactivity as the culprit of metabolic inflexibility: evidences from bed-rest studies. J Appl Physiol 2011; 111: 1201-1210.
98. Garland Jr T, Schutz H, Chappell MA, Keeney BK, Meek TH, Copes LE et al. The biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectives. J Exp Biol 2011; 214 (Pt 2): 206-229.
99. Hamilton MT, Hamilton DG, Zderic TW. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 2007; 56: 2655-2667.